This article examines private industry's involvement in the area of clinical laboratory testing, as an example of the relationship between the increased cost of medical care and increased involvement of private industry in the health care sector. After tracing the history of corporate and technological development in the clinical laboratory field, and particularly in the area of blood chemistry analysis, the article suggests some implications for public policy of the current state of affairs.

You do not currently have access to this content.